![](https://scx1.b-cdn.net/csz/news/tmb/2021/tirbanibulin.jpg)
Tirbanibulin superior to placebo for actinic keratosis
(HealthDay)—Tirbanibulin is superior to vehicle at two months for the treatment of actinic keratosis, but almost half of patients who had a complete response experienced recurrence of lesions at one year, according to a ...
Feb 11, 2021
0
1